BRIEF published on 03/19/2025 at 15:32, 14 days 11 hours ago Valerio Therapeutics Announces Board Members and Their Roles Board Members Valerio Therapeutics Corporate Roles Paris-based Company Executive Responsibilities
PRESS RELEASE published on 03/19/2025 at 15:27, 14 days 11 hours ago Inside Information / Other news releases Valerio Therapeutics announces new board members and their positions in other companies as of March 19, 2025 Board Members Positions Valerio Therapeutics Other Companies March 19 2025
BRIEF published on 03/19/2025 at 12:35, 14 days 14 hours ago Valerio Therapeutics Board Meeting Decisions Director Changes Shareholder Meeting Share Split Board Resolutions Article Amendments
PRESS RELEASE published on 03/19/2025 at 12:30, 14 days 14 hours ago Inside Information / Other news releases Valerio Therapeutics Board of Directors convenes a General Meeting with resolutions on director dismissals, co-optation, share division, bylaws amendment, and formalities powers Board Of Directors General Meeting Resolutions Valerio Therapeutics Share Division
BRIEF published on 02/04/2025 at 10:40, 1 month 26 days ago Valerio Therapeutics opts for strategic refocusing Clinical Trials Oncology Financial Strategy Medical Innovation Valerio Therapeutics
PRESS RELEASE published on 02/04/2025 at 10:35, 1 month 26 days ago Inside Information / Other news releases Valerio Therapeutics refocuses strategy, discontinuing clinical trials for financial reasons. Focus on early-stage drug development Clinical Trials Financial Challenges Valerio Therapeutics Strategy Refocus Early-stage Development
BRIEF published on 10/01/2024 at 00:56, 6 months 2 days ago Valerio Therapeutics Reports First Half 2024 Financial Results Financial Results R&D Clinical Trial Valerio Therapeutics Single Domain Antibodies
BRIEF published on 10/01/2024 at 00:45, 6 months 2 days ago Valerio Therapeutics Reports Half-Year 2024 Financial Results and Strategic Updates Financial Results Emglev Acquisition VIO-01 Clinical Trial PlatON™ Platform Therapeutic Innovations
PRESS RELEASE published on 10/01/2024 at 00:40, 6 months 2 days ago Inside Information: News release on accounts, results Valerio Therapeutics reports its half-year 2024 financial results and updates on its activities, including the acquisition of Emglev Therapeutics and progress on the VIO-01 trial Acquisition Financial Results Valerio Therapeutics VIO-01 Trial Emglev Therapeutics
PRESS RELEASE published on 09/30/2024 at 22:40, 6 months 2 days ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report
Published on 04/03/2025 at 01:35, 1 hour 14 minutes ago GMV Minerals Inc. Closes Non-Brokered Financing/ Engages Investor Relations Firm
Published on 04/02/2025 at 23:35, 3 hours 14 minutes ago Murchison Minerals to Seek Shareholders’ Approval for Share Consolidation
Published on 04/02/2025 at 20:00, 6 hours 49 minutes ago Network-1 Announces Acquisition of Patent Portfolio
Published on 04/02/2025 at 15:00, 11 hours 49 minutes ago Doubleview Gold Corp 2025 Exploration Program
Published on 04/02/2025 at 20:20, 6 hours 29 minutes ago EQS-Adhoc: Siemens Aktiengesellschaft: Siemens acquires Dotmatics to extend AI-powered software portfolio to Life Sciences
Published on 04/02/2025 at 20:01, 6 hours 48 minutes ago Annual General Meeting of Deutsche Konsum REIT-AG successfully held
Published on 04/02/2025 at 20:01, 6 hours 48 minutes ago Travis Perkins: Publication of the Annual Report and Accounts 2024
Published on 04/02/2025 at 19:40, 7 hours 9 minutes ago LION E-Mobility AG starts successfully into the new 2025 financial year – Challenging market environment impacts 2024
Published on 04/02/2025 at 19:13, 7 hours 36 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/03/2025 at 00:37, 2 hours 12 minutes ago Publication of the report on payments made to governments provided by article L.225-102-3 of the French Commercial Code
Published on 04/02/2025 at 17:45, 9 hours 4 minutes ago Aéroports de Paris SA - Voting rights as of 31 March 2025
Published on 04/02/2025 at 17:45, 9 hours 4 minutes ago Availability of the Pre-Q1 2025 Sales Communication
Published on 04/02/2025 at 17:45, 9 hours 4 minutes ago Information concerning the total number of voting rights and shares 2025 03 31
